JP2007536282A5 - - Google Patents

Download PDF

Info

Publication number
JP2007536282A5
JP2007536282A5 JP2007511768A JP2007511768A JP2007536282A5 JP 2007536282 A5 JP2007536282 A5 JP 2007536282A5 JP 2007511768 A JP2007511768 A JP 2007511768A JP 2007511768 A JP2007511768 A JP 2007511768A JP 2007536282 A5 JP2007536282 A5 JP 2007536282A5
Authority
JP
Japan
Prior art keywords
peptide
bone
growth hormone
mammal
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007511768A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007536282A (ja
JP4931802B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2005/000638 external-priority patent/WO2005105132A1/en
Publication of JP2007536282A publication Critical patent/JP2007536282A/ja
Publication of JP2007536282A5 publication Critical patent/JP2007536282A5/ja
Application granted granted Critical
Publication of JP4931802B2 publication Critical patent/JP4931802B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007511768A 2004-05-04 2005-05-04 骨障害を予防または治療するための方法 Expired - Fee Related JP4931802B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004902388 2004-05-04
AU2004902388A AU2004902388A0 (en) 2004-05-04 Methods for preventing or treating bone disorders
PCT/AU2005/000638 WO2005105132A1 (en) 2004-05-04 2005-05-04 Methods for preventing or treating bone disorders

Publications (3)

Publication Number Publication Date
JP2007536282A JP2007536282A (ja) 2007-12-13
JP2007536282A5 true JP2007536282A5 (https=) 2008-06-26
JP4931802B2 JP4931802B2 (ja) 2012-05-16

Family

ID=35241438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007511768A Expired - Fee Related JP4931802B2 (ja) 2004-05-04 2005-05-04 骨障害を予防または治療するための方法

Country Status (8)

Country Link
US (1) US8008433B2 (https=)
EP (1) EP1755637B8 (https=)
JP (1) JP4931802B2 (https=)
CN (1) CN1950103B (https=)
AU (1) AU2005237187B2 (https=)
CA (1) CA2564169C (https=)
ES (1) ES2391853T3 (https=)
WO (1) WO2005105132A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1919506A1 (en) * 2005-08-02 2008-05-14 Metabolic Pharmaceuticals Ltd. Peptide conjugate for oral delivery of hydrophilic peptide analgesics
WO2007068039A1 (en) * 2005-12-12 2007-06-21 Metabolic Pharmaceuticals Limited Treatment of weight gain in estrogen deficient mammals
CA2857686C (en) * 2011-12-09 2023-01-17 Metabolic Pharmaceuticals Pty Ltd Use of growth hormone fragments
IT202100002228A1 (it) * 2021-02-02 2022-08-02 Univ Degli Studi Milano Composizione per ridurre gli squilibri metabolici conseguenti all'insufficienza ovarica

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
BR9811755A (pt) * 1997-09-08 2000-08-29 Metabolic Pharmaceutical Ltd Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica
EP1200432B1 (en) * 1999-07-13 2004-05-12 Merck & Co., Inc. Amido spiropiperidines promote the release of growth hormone
AUPQ387599A0 (en) 1999-11-05 1999-12-02 Metabolic Pharmaceuticals Limited Product and method for control of obesity
AU2001285145A1 (en) * 2000-08-21 2002-03-04 Millennium Pharmaceuticals, Inc. Human abc transporter family member and uses thereof
US20040208866A1 (en) * 2002-10-07 2004-10-21 Jaspers Stephen R. Methods of regulating body weight

Similar Documents

Publication Publication Date Title
AP860A (en) Dipeptide compounds which are growth hormone secretegoques.
JP5000848B2 (ja) グレリン含有医薬組成物
CN101189021B (zh) 用于控制、预防和治疗肥胖和进食障碍的组合物和方法
JP4173914B2 (ja) Ｏｂ蛋白組成物を用いる非脂肪組織重増加方法
US8602998B2 (en) Use of relaxin to increase arterial compliance
CZ298292B6 (cs) Vodný farmaceutický prostředek s obsahem růstového hormonu a jeho použití
JP2014169310A (ja) Ｅｔｂ受容体アゴニストを用いた脳卒中または脳血管障害の治療方法
US20240325397A1 (en) Use of combination therapy for treating cancer
CN1878555A (zh) 包含n－(3－甲氧基－5－甲基吡嗪－2－基)－2－(4－[1,3,4－噁二唑－ 2－基]苯基)吡啶－3－磺酰胺与lhrh类似物和/或二膦酸盐的联合药物
US4652547A (en) Pharmaceutical formulations comprising human insulin and human proinsulin
PT1397156E (pt) Método para a administração oral da hormona paratireóide ( pth ).
US20020094951A1 (en) Dental remedies containing pth
JP2007536282A5 (https=)
ES2980806T3 (es) Combinación de análogos de la somatostatina con inhibidores de la 11-beta-hidroxilasa
CA2559745C (en) Use of relaxin to increase arterial compliance
JP4931306B2 (ja) 骨形成を安全に促進させる医薬複合剤
Hanssen et al. Extended Experience with Recombinant a-2b Interferon with OR Without Hepatic Artery Embolization in the Treatment OF Midgut Carcinoid Tumours A preliminary report
GB2104380A (en) Human proinsulin pharmaceutical formulations
JP2007519669A (ja) 脂肪異栄養症を治療するための方法及び組成物
JP5300943B2 (ja) 骨形成を安全に促進させる医薬複合剤
EP0672420A1 (en) Wound remedy
JP5454805B2 (ja) 骨形成を安全に促進させる医薬複合剤
US20030207811A1 (en) Method of treating retinopathy of prematurity using somatostatin analogs
Hanssen et al. EXTENDED EXPERIENCE WITH RECOMBINANT a-2b INTERFERON WITH OR WITHOUT HEPATIC ARTERY EMBOLIZATION IN THE TREATMENT OF MIDGUT CARCINOID TUMOURS
JPH1192395A (ja) Ｐｔｈを含有する歯科治療剤